Caribou Biosciences, Inc. is a United States-based clinical-stage biotechnology company. The Company uses clustered regularly interspaced short palindromic repeats (CRISPR) genome editing to discover and develop immune cell-based therapeutics for can... Read more
SeekingAlpha
CNBC
CNBC
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.